140 related articles for article (PubMed ID: 29956844)
1. Acute electrophysiologic effects of the polyphenols resveratrol and piceatannol in rabbit atria.
Frommeyer G; Wolfes J; Ellermann C; Kochhäuser S; Dechering DG; Eckardt L
Clin Exp Pharmacol Physiol; 2019 Jan; 46(1):94-98. PubMed ID: 29956844
[TBL] [Abstract][Full Text] [Related]
2. Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure.
He Z; Sun C; Xu Y; Cheng D
Biomed Pharmacother; 2016 Dec; 84():1760-1767. PubMed ID: 27847200
[TBL] [Abstract][Full Text] [Related]
3. Divergent antiarrhythmic effects of resveratrol and piceatannol in a whole-heart model of long QT syndrome.
Ellermann C; Wolfes J; Kochhäuser S; Dechering DG; Reinke F; Wasmer K; Eckardt L; Frommeyer G
Int J Cardiol; 2017 Sep; 243():233-238. PubMed ID: 28606656
[TBL] [Abstract][Full Text] [Related]
4. Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.
Frommeyer G; Sterneberg M; Dechering DG; Kaese S; Bögeholz N; Pott C; Fehr M; Bogossian H; Milberg P; Eckardt L
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039911
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol prevents atrial fibrillation by inhibiting atrial structural and metabolic remodeling in collagen-induced arthritis rats.
Zhang Y; Zhang S; Liu Z; Zhao X; Yuan Y; Sheng L; Li Y
Naunyn Schmiedebergs Arch Pharmacol; 2018 Nov; 391(11):1179-1190. PubMed ID: 30135998
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan differentially modulates electrophysiological activities of sinoatrial nodes, pulmonary veins, and the left and right atria.
Lin YK; Chen YC; Chen YA; Huang JH; Chen SA; Chen YJ
J Cardiovasc Electrophysiol; 2018 Aug; 29(8):1150-1158. PubMed ID: 29733479
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human atrial electrophysiology.
Kumar S; Sutherland F; Rosso R; Teh AW; Lee G; Heck PM; Feldman A; Medi C; Watt S; Garg ML; Sparks PB
Heart Rhythm; 2011 Apr; 8(4):562-8. PubMed ID: 21147262
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
Frommeyer G; Milberg P; Uphaus T; Kaiser D; Kaese S; Breithardt G; Eckardt L
Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657
[TBL] [Abstract][Full Text] [Related]
9. Anti-arrhythmic effects of I (Na), I (Kr), and combined I (Kr)-I (CaL) blockade in an experimental model of acute stretch-related atrial fibrillation.
Kalifa J; Bernard M; Gout B; Bril A; Cozma D; Laurent P; Chalvidan T; Deharo JC; Djiane P; Cozzone P; Maixent JM
Cardiovasc Drugs Ther; 2007 Feb; 21(1):47-53. PubMed ID: 17356910
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol and derivatives for the treatment of atrial fibrillation.
Baczkó I; Light PE
Ann N Y Acad Sci; 2015 Aug; 1348(1):68-74. PubMed ID: 26205342
[TBL] [Abstract][Full Text] [Related]
11. Effects of high dose intravenous fish oil on human atrial electrophysiology: implications for possible anti- and pro-arrhythmic mechanisms in atrial fibrillation.
Kumar S; Sutherland F; Lee JM; Robinson T; Heck PM; Wong MC; Kelland NF; Garg ML; Sparks PB
Int J Cardiol; 2013 Oct; 168(3):2754-60. PubMed ID: 23602291
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological effects of an anti-influenza drug oseltamivir on the guinea-pig atrium: comparison with those of pilsicainide.
Takahara A; Suzuki S; Hagiwara M; Nozaki S; Sugiyama A
Biol Pharm Bull; 2013; 36(10):1650-2. PubMed ID: 24088258
[TBL] [Abstract][Full Text] [Related]
13. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
[TBL] [Abstract][Full Text] [Related]
14. Red Wine, Resveratrol and Atrial Fibrillation.
Stephan LS; Almeida ED; Markoski MM; Garavaglia J; Marcadenti A
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29084143
[TBL] [Abstract][Full Text] [Related]
15. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
[TBL] [Abstract][Full Text] [Related]
16. [Acute electrophysiological modulation of the atria and pulmonary veins: effects of sympathetic and parasympathetic interaction on atrial fibrillation inducibility].
Oliveira M; Postolache G; Geraldes V; Silva V; Laranjo S; Tavares C; da Silva MN; Ferreira R; Rocha I
Rev Port Cardiol; 2012 Mar; 31(3):215-23. PubMed ID: 22326990
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of IKr potentiates development of atrial-selective INa block leading to effective suppression of atrial fibrillation.
Burashnikov A; Belardinelli L; Antzelevitch C
Heart Rhythm; 2015 Apr; 12(4):836-44. PubMed ID: 25546810
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic actions of dl-sotalol in patients with persistent atrial fibrillation.
Tse HF; Lau CP
J Am Coll Cardiol; 2002 Dec; 40(12):2150-5. PubMed ID: 12505228
[TBL] [Abstract][Full Text] [Related]
19. Diadenosine-5-phosphate exerts A1-receptor-mediated proarrhythmic effects in rabbit atrial myocardium.
Brandts B; Borchard R; Dirkmann D; Wickenbrock I; Sievers B; van Bracht M; Prull MW; Trappe HJ
Br J Pharmacol; 2003 Aug; 139(7):1265-72. PubMed ID: 12890705
[TBL] [Abstract][Full Text] [Related]
20. The role of stretch-activated channels in atrial fibrillation and the impact of intracellular acidosis.
Ninio DM; Saint DA
Prog Biophys Mol Biol; 2008; 97(2-3):401-16. PubMed ID: 18367236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
